Rojas C, Gálvez-Jirón F, De Solminihac J, Padilla C, Cárcamo I, Villalón N, Kurte M, and Pino-Lagos K. Journal of Immunology Research, 2022.
This review examines the bidirectional relationship between the human microbiota and the immune system, emphasizing how microorganisms inhabiting different anatomical sites contribute to immune homeostasis and how alterations in these microbial communities can promote inflammation and disease. Rather than considering microorganisms merely as potential pathogens, the authors describe the microbiota as an integral component of local tissue environments that continuously interacts with epithelial cells, innate and adaptive immune cells, and soluble mediators.
A central concept of the article is the distinction between microbiome and microbiota. The microbiome encompasses not only microorganisms and their genetic material but also their interactions, functions, spatial and temporal characteristics, and relationship with the host. Microbiota refers more specifically to the microorganisms present within a particular environment. The review stresses that microbial communities vary considerably among anatomical sites and that their composition is shaped by local physiological conditions.
The authors highlight that the relationship between microbiota and immunity is reciprocal. The immune system controls microbial populations through mechanisms involving pattern-recognition receptors (PRRs), Toll-like receptors (TLRs), NOD-like receptors, antimicrobial peptides, immunoglobulins, cytokines, and specialized immune-cell populations. At the same time, commensal microorganisms regulate the development and function of the immune system. Evidence from germ-free and immunodeficient animals illustrates this interdependence: alterations in immune function modify microbial composition, whereas the absence of normal microbiota affects B cells, IgA production, inflammatory responses, and immune maturation.
Microbiota at different anatomical sites
The ocular microbiota, once considered relatively scarce, is now known to include bacterial, fungal, and viral communities. Important bacterial genera include Haemophilus, Streptococcus, Staphylococcus, Propionibacterium, and Corynebacterium. Under normal conditions, microorganisms coexist with epithelial and immune cells within what the authors describe as the “ocular surface microenvironment,” contributing to immune tolerance and tissue homeostasis. Disruption of the epithelial barrier can expose microbial components to receptors such as TLR5 and initiate inflammation. Conversely, some commensals have protective effects: Corynebacterium mastitidis, for example, stimulates IL-17-producing γδ T cells and neutrophil recruitment, helping protect the ocular surface against pathogens. The review also discusses evidence connecting intestinal dysbiosis with ocular diseases such as uveitis and potentially glaucoma.
The oral cavity contains one of the body’s most diverse microbial ecosystems, with approximately 1,000 described species occupying distinct niches. Here, the immune system faces the challenge of controlling pathogens while tolerating a large population of harmless commensals. PRRs on epithelial and innate immune cells detect microbial signals, while dendritic cells (DCs), Langerhans cells, T cells, Tregs, and secretory IgA participate in determining whether the response becomes inflammatory or tolerogenic. Under non-inflammatory conditions, dendritic cells can promote IL-10-producing T cells and Treg-mediated suppression. Secretory IgA also restricts microbial colonization while helping maintain tolerance. Dysregulation of these mechanisms is associated with conditions such as periodontitis.
In the lung, microbial communities coexist with an immune environment that normally favors tolerance. Airway epithelial cells provide a physical and immunological barrier, while alveolar macrophages produce mediators such as prostaglandins and TGF-β and can promote Treg differentiation through TGF-β and retinoic acid. Experimental evidence indicates that microbiota contribute directly to this regulatory state: germ-free mice develop stronger inflammatory responses than conventionally colonized animals, and recolonization can reverse some of these effects. The diagram in Figure 3 (page 6) summarizes this network, showing how epithelial cells, macrophages, dendritic cells, Tregs, soluble mediators, and resident bacteria collectively maintain pulmonary immune tolerance.
Pulmonary dysbiosis is also associated with chronic respiratory diseases. Asthma, COPD, and chronic suppurative lung diseases show alterations in microbial composition, including changes in Haemophilus, Neisseria, Prevotella, Veillonella, and Proteobacteria. Importantly, the authors extend this concept beyond the lung itself by discussing the gut–lung axis: changes in intestinal microbiota, caused for example by diet or antibiotics, may influence susceptibility to pulmonary inflammation and disease.
The gastrointestinal microbiota represents one of the most extensive examples of microbiota–immune crosstalk. Microbial metabolites, particularly short-chain fatty acids such as butyrate, acetate, and propionate, contribute to intestinal homeostasis by promoting tissue repair and inducing regulatory populations such as Tregs and tolerogenic DCs. Intestinal microorganisms also influence neutrophils and the differentiation of Th1, Th2, Th17, and Treg populations. Thus, microbial products can determine the balance between inflammatory and regulatory immune responses.
When this balance is disrupted, intestinal dysbiosis is associated with inflammatory bowel diseases such as Crohn’s disease and ulcerative colitis, which are characterized by reduced microbial diversity and changes in specific bacterial populations. The review also discusses relationships between intestinal microbiota and type 1 diabetes, allergic disease, and cancer. In cancer, microbial imbalance may promote chronic inflammation or generate metabolites capable of affecting epithelial cells, while alterations in gut microbiota may also influence tumors outside the intestine through systemic inflammatory and metabolic mechanisms.
The genitourinary microbiota, particularly the vaginal microbiota, provides another example of microbial communities contributing directly to tissue protection. In healthy women, the vaginal environment is predominantly populated by Lactobacillus species, which form protective biofilms, compete with potential pathogens, and produce substances such as lactic acid and hydrogen peroxide. These mechanisms help preserve epithelial integrity and prevent pathogen colonization. A reduction in Lactobacillus and expansion of anaerobic bacteria characterize bacterial vaginosis, which is associated with epithelial disruption, altered immune homeostasis, and increased susceptibility to sexually transmitted infections. Certain Lactobacillus species can also reduce inflammatory mediators such as IL-6, IL-8, and TNF-α.
The urinary tract also contains microbial communities and possesses multiple antimicrobial defense mechanisms. During E. coli infection, epithelial responses stimulate inflammatory signaling and immune-cell recruitment. Lactoferrin, uromodulin, IgA, cathelicidin, and defensins limit bacterial adherence, while IL-6 and IL-8 promote neutrophil migration. The authors additionally discuss the reproductive tract during pregnancy, where immunity must simultaneously protect against infection and tolerate the semiallogeneic fetus. j-immunol-res-2022-11
Finally, the skin microbiota is strongly influenced by local environmental conditions, including pH, humidity, temperature, skin thickness, and anatomical location. Microbial colonization beginning early in life contributes to immune tolerance, particularly through Tregs. Commensal organisms can protect against pathogens by producing antimicrobial molecules, but they can also directly regulate host immunity. For example, Staphylococcus epidermidis can promote IL-17- and IFN-γ-producing T cells during antimicrobial responses while, in other contexts, reducing inflammation through TLR2-dependent signaling. The schematic in Figure 5 (page 8) integrates these relationships among resident bacteria and fungi, Tregs, Th1/Th17 cells, dendritic cells, Langerhans cells, cytokines, and environmental factors.
Central immunological message
Across all these anatomical sites, the review identifies a common principle: health depends not simply on the presence or absence of particular microorganisms, but on a balanced interaction between microbial communities, tissue barriers, and the immune system. Commensal microorganisms can stimulate immune defenses against pathogens while simultaneously promoting regulatory mechanisms that prevent excessive inflammation. Key elements repeatedly involved in this balance include TLRs and other PRRs, dendritic cells, macrophages, Tregs, Th17 cells, IgA, IL-10, TGF-β, IL-17, and microbial metabolites such as short-chain fatty acids.
Consequently, dysbiosis should be understood as both a potential consequence and a contributor to immune dysfunction. Changes in microbial diversity or composition can alter immune signaling and promote inflammation, but abnormal immune responses can themselves reshape microbial communities. The paper therefore presents microbiota–immunity interactions as dynamic, bidirectional networks rather than simple cause-and-effect relationships.
The review also emphasizes that these interactions are not necessarily restricted to the anatomical site where the microorganisms reside. Gut microbiota, for example, may influence pulmonary disease and skin inflammation, while intestinal microbial alterations have been associated with ocular disorders. This suggests that microbial products and immune mediators can connect anatomically distant tissues, creating systemic axes of communication.
Conclusion
The authors conclude that the microbiota–immune system relationship is fundamental both for maintaining homeostasis and for determining responses during disease. A healthy microbiota supports epithelial integrity, immune maturation, antimicrobial defense, and immune tolerance, whereas disturbances in this equilibrium can contribute to chronic inflammatory, infectious, allergic, metabolic, and neoplastic conditions. Future technological developments and a better mechanistic understanding of these interactions may enable microbiota-directed interventions for disease prevention or treatment.
Importantly, this paper is a review article rather than an original experimental study: it integrates evidence from previous research across multiple anatomical systems and does not report a new experimental dataset. The authors explicitly state that no data were used to support the study and that the article itself contains no human or animal experiments.